busulphan

busulphan

Busulfan, an alkylating anticancer drug used especially in the treatment of chronic granulocytic LEUKAEMIA. It is very toxic and can destroy the function of the BONE MARROW unless its use is carefully monitored. It can also cause widespread FIBROSIS of the lungs. A brand name is Myleran.
References in periodicals archive ?
Busulphan (Busulfex) is a cancer drug, in use since 1959.
Chemotherapy, particularly with alkylating agents such as busulphan, ionizing radiotherapy in the abdomen or pelvic region, gynecological malignancies surgery, can permanently destroy gonads and lead to infertility and premature menopause (6, 7).
The conditioning regimes were as follows: cyclophosphamide in four patients with AA, ATG only in hepatitis associated AA in the case of syngeneic transplantation, cyclophosphamide + busulphan in 23 patients, busulphan+ fludarabine in three cases with reduced conditioning, busulphan + cyclophosphamide + ATG in one patient, busulphan + cyclophosphamide + etoposide in one patient, fludarabine + melphalan in one case, and TBI in one patient.
(3) Table 3: Activity of 21 antineoplastic agents against 4 groups of pathogenic microorganisms, expressed in semiquantitative terms Activity against indicated type of organism Gram- Gram- Antineoplastic positive negative Agent bacteria bacteria Alkylating agents Carmustine 0 0 Chlorambecil 0 0 Neoplatin 0 + No activity shown by busulphan, cyclophosphamide, dibromomannitol, and melphalan.
The most commonly used regimes in children are the regimes in which cyclophosphamide and busulphan are used together (23).
Hence, several drugs such as local anesthetics and their metabolites, the anticancer drugs roscovitine, olomoucine, busulphan, cyclophosphamide, and AZD3409, the [beta]-blockers acebutolol and metoprolol, the neurotransmitters dopamine and serotonin, methadone, and cocaine and cocaine metabolites have been extracted from biological samples such as blood, plasma, or urine samples using MEPS [18-22, 121-153].
As we have described previously [8, 9] and confirmed again in our patient population, the use of CsA+MTX versus CsA+MMF or conditioning with busulphan versus melphalan had no impact on the occurrence of grade 2-4 aGHVD; so we analyzed all the patients as a whole group.
The myeloablative conditioning regimen consisted of hyperfractionated total body irradiation (13.2 Gy in 8 fractions) plus Cyclophosphamide (60 mg/kg/day for 2 consecutive days), Busulphan (0.8 mg/kgi.v.
Radiotherapy and chemotherapy with alkylating agents (e.g., busulphan, cyclophosphamide and dacarbazine) are DNA-damaging treatments, affecting both cancer and healthy cells.
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning.